Literature DB >> 9476186

Prevalence and incidence of cholelithiasis in patients with liver cirrhosis.

A Maggi1, D Solenghi, A Panzeri, G Borroni, M Cazzaniga, A Sangiovanni, C De Fazio, F Salerno.   

Abstract

AIMS: To evaluate the prevalence, the incidence and the history of cholelithiasis in liver cirrhosis. PATIENTS AND METHODS: A series of 233 consecutive cirrhotic patients (193 Child A, 35 Child B and 5 Child C) were assessed for cholelithiasis by ultrasonography. Of these, 201 (those who had never had cholecystectomy) were followed-up with repeated ultrasonographies.
RESULTS: The prevalence of cholelithiasis was 38% (22% gallstones and 16% previous cholecystectomies). No relationships with the usual risk factors for cholesterol gallstones, such as age, sex, body mass index, serum glucose or triglycerides, were found. On the contrary, close correlations were observed with serum albumin, bilirubin, prothrombin time and Pugh score. By multivariate analysis, only serum bilirubin was independently correlated with cholelithiasis. Histories of biliary pain were more frequent in patients with previous cholecystectomy (62% cases) than in those with gallstones (21%) and those without cholelithiasis (7%). On the contrary, complaints of dyspepsia were similar in the three groups of patients. During a mean follow-up of 34.4 +/- 0.9 months, there was a 4.9% annual rate of development of new stones in 127 patients without cholelithiasis at the first investigation. This rate is markedly higher than that reported for normal subjects in a previous survey carried out in a similar geographic area. During a mean follow-up of 31.8 +/- 1.2 months, symptoms or complications were seen in 2 out of 45 patients with initial gallstones (4.4%). The annual rate of complications was estimated to be less than 2%.
CONCLUSIONS: Cholelithiasis is frequently associated with cirrhosis and the risk of developing new stones remains high during the natural history of the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9476186

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  8 in total

Review 1.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

2.  Management of common bile duct stones in cirrhotic patients with coagulopathy: a comparison of supra-papillary puncture and standard cannulation technique.

Authors:  Everson L A Artifon; Eduardo B da Silveira; Dayse Aparicio; Jonas Takada; Renato Baracat; Christiano M Sakai; Ruel T Garcia; Vanessa Teich; Decio S Couto
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

Review 3.  Laparoscopic or open cholecystectomy in cirrhosis: a systematic review of outcomes and meta-analysis of randomized trials.

Authors:  Jerome M Laurence; Peter D Tran; Arthur J Richardson; Henry C C Pleass; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2012-01-18       Impact factor: 3.647

Review 4.  Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Authors:  Bipadabhanjan Mallick; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

Review 5.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Gallbladder contractility in liver cirrhosis: comparative study in patients with and without gallbladder stones.

Authors:  Monica Acalovschi; Dan L Dumitrascu; Cezar D Nicoara
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

7.  Case report of cholelithiasis in a patient with type 1 Gaucher disease.

Authors:  Afrim Avdaj; Naim Fanaj; Mirsade Osmani; Agron Bytyqi; Anila Cake
Journal:  Int J Surg Case Rep       Date:  2016-11-11

Review 8.  Gallstones in Patients with Chronic Liver Diseases.

Authors:  Xu Li; Xiaolin Guo; Huifan Ji; Ge Yu; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-01-31       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.